Señales en vivo de ANIK | Maximiza tus Ganancias con Getagraph.com

VENDER 109571 min ago

@ $23.63

Emitido: 14 feb 2024 @ 09:30

Retorno: 8.65%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: 0.60 %

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 12:41):

Stats
Volumen de hoy	8 168.00
Volumen promedio	79 122.00
Capitalización de mercado	381.27M
EPS	$0 ( 2024-03-13 )
Próxima fecha de ganancias	( $-0.190 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.55
ATR14	$0.0580 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Levitz Michael L	Buy	51 682	Stock Option (Right to Buy)
2024-03-15	Levitz Michael L	Buy	21 329	Restricted Stock Unit
2024-03-15	Colleran David	Buy	46 875	Stock Option (Right to Buy)
2024-03-15	Colleran David	Buy	19 345	Restricted Stock Unit
2024-03-15	Nunes Anne	Buy	26 442	Stock Option (Right to Buy)

INSIDER POWER
51.59
Last 100 transactions
Buy: 1 044 875 \| Sell: 338 384

Volumen Correlación

Largo: -0.09 (neutral)

Corto: -0.17 (neutral)

Signal:(36.52) Neutral

Anika Therapeutics Inc Correlación

10 Correlaciones Más Positivas
RMRM	0.905
BPTH	0.892
GOODN	0.886
RMGC	0.883
MLVF	0.875
BCOV	0.872
ALLT	0.87
WISH	0.868
GOODO	0.868
APTX	0.868

10 Correlaciones Más Negativas
PTRS	-0.908
AAON	-0.874
ULBI	-0.866
CORT	-0.859
PXI	-0.855
STEP	-0.842
PSCE	-0.84
TUR	-0.838
GSHD	-0.837
FTXN	-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anika Therapeutics Inc Correlación - Moneda/Commodity

0.59
( weak )

0.68
( moderate )

0.00
( neutral )

0.79
( moderate )

-0.45
( neutral )

0.02
( neutral )

Anika Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$166.66M
Beneficio Bruto:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2023
Ingresos:	$166.66M
Beneficio Bruto:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2022
Ingresos:	$156.24M
Beneficio Bruto:	$93.58M (59.89 %)
EPS:	$-1.020

FY	2021
Ingresos:	$147.79M
Beneficio Bruto:	$82.94M (56.12 %)
EPS:	$0.290

Financial Reports:

No articles found.

Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.